| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 345.66B | 349.35B | 344.15B | 319.50B | 286.48B | 269.20B |
| Gross Profit | 54.54B | 54.29B | 52.48B | 40.04B | 38.91B | 38.05B |
| EBITDA | 31.08B | 35.94B | 37.06B | 24.81B | 23.34B | 24.10B |
| Net Income | 8.74B | 11.86B | 13.74B | 1.19B | 83.00M | 732.00M |
Balance Sheet | ||||||
| Total Assets | 338.47B | 333.53B | 357.49B | 328.45B | 342.75B | 343.14B |
| Cash, Cash Equivalents and Short-Term Investments | 101.31B | 97.91B | 102.25B | 75.79B | 74.56B | 78.75B |
| Total Debt | 144.51B | 160.31B | 170.99B | 178.86B | 188.09B | 196.57B |
| Total Liabilities | 214.97B | 222.65B | 234.91B | 241.49B | 254.55B | 266.92B |
| Stockholders Equity | 110.69B | 95.70B | 101.64B | 66.77B | 68.02B | 58.37B |
Cash Flow | ||||||
| Free Cash Flow | 20.52B | 29.24B | 31.13B | 19.75B | 770.00M | 7.80B |
| Operating Cash Flow | 32.12B | 38.02B | 41.51B | 29.62B | 12.00B | 15.41B |
| Investing Cash Flow | -10.71B | -6.88B | -5.24B | -9.17B | -6.84B | -6.66B |
| Financing Cash Flow | -20.30B | -33.92B | -13.79B | -20.68B | -13.03B | 12.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥415.66B | 6.79 | 8.36% | 2.71% | 0.75% | 35.26% | |
81 Outperform | ¥258.46B | 8.29 | ― | 3.36% | 1.36% | 139.77% | |
76 Outperform | ¥705.91B | 14.05 | 7.20% | 2.41% | -0.73% | 88.36% | |
75 Outperform | ¥482.87B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
74 Outperform | ¥141.48B | 10.91 | ― | 2.93% | 1.77% | 117.03% | |
70 Outperform | ¥54.98B | 14.59 | ― | 0.99% | -0.83% | -27.20% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |